Bladder Cancer Update & Renal Cell Cancer Update, 2017 (Video Program)


Case discussion: A 52-year-old man who initially receives treatment for nonmuscle-invasive UBC presents 4 years later with metastatic disease
6:09 minutes.

BLADDER CANCER
(Neo)adjuvant treatment for urothelial bladder cancer (UBC)

Therapeutic options for patients with advanced UBC

Immune checkpoint blockade in UBC

RENAL CELL CANCER
Adjuvant sorafenib or sunitinib for renal cell carcinoma (RCC)

Selection and sequencing of therapeutic options for advanced RCC

Immune checkpoint blockade in RCC